Luxembourg
Le Ministère de la Santé of Luxembourg reminds all MAHs to notify to the Minister of Health in cases of temporary or permanent interruption of the placing on the market for the medicinal product no later than two months before this interruption and inform the Minister of the reason for such action. A shorter notice period is permitted under exceptional circumstances. The MAH’s are therefore reminded to notify any case of discontinuation of the marketing of a medicinal product marketing authorization which has actually been placed on the market in Luxembourg by means of the notification form to infoshortages@ms.etat.lu.
Source: http://www.apl-pharma.lu/docs/legis/19-07-31-courrier-ruptures-misa.pdf